This is a concise introduction to the study of medication utilization and safety in large populations of people. "Understanding Pharmacoepidemiology" is a clear, engagingly written roadmap to mastering the important concepts and methods of pharmacoepidemiology. It explains what pharmacoepidemiology is, how pharmacoepidemiology studies are conducted, and how to interpret findings. You will learn the importance of pharmacoepidemiology, basic terminology used in research, and the data sources, study designs, and statistical analyses employed in pharmacoepidemiology research. Upon completing "Understanding Pharmacoepidemiology" you will have a better understanding of how to evaluate the associations between medication utilization and outcomes. Each chapter includes these valuable learning aids: a list of learning objectives; case studies or examples; discussion questions; and, tables and figures. You will also find a glossary of important words and terms. The content you need to understand the concepts and methods of pharmacoepidemiology: Introduction to Pharmacoepidemiology: Principles of Epidemiology Applied to the Study of Medication Use, Study Designs in Pharmacoepidemiology; Using Secondary Data in Pharmacoepidemiology; Biostatistics and Pharmacoepidemiology: Other Methodological Issues; Evaluation of Pharmacoepidemiology Literature; Medication Utilization Patterns; Medication Safety and Pharmacovigilance; and, FDA Perspectives on Post-market Drug Safety.
Part 1; Chapter 1. What is pharmacoepi; Chapter 2. Why is pharmacoepi important (Importance to pharmacy practice); Chapter 3. Principles of epidemiology applied to the study of drug use; Chapter 4. Study Designs (Observational study, Experimental study, Case report, Meta-analysis); Chapter 5. Data Sources (Pharmacy claims data, Validity of data, Defining exposure, Defining outcomes); Chapter 6. Medication Safety Pharmacovig (Use of pharmacoepi to study beneficial drug effects, Use of pharmacoepi to study adverse drug effects); Chapter 7. Continual Monitoring for Unwanted Drug Effects (Post-marketing surveillance); Chapter 8. Applications in Pharmacy Practice; Part 2; Chapter 9. Medication Adherence; Chapter 10. Statistics in Pharmacoepi; Chapter 11. International Perspective (global drug surveillance); Chapter 12. Other Methodological Issues (Causality, Confounding); Chapter 13. Future Issues; Part 3; Chapter 14. Case Studies or Examples; Chapter 15. Learning Objectives; Glossary; Q & A, Questions; Discussion Questions
Author Profiles Donna West, Ph.,Ph.D. University of Mississippi Chair of Pharmacy Administration University, MS Donna West-Strum most recently was associate professor in the Division of Pharmaceutical Evaluation and Policy at the University of Arkansas for Medical Sciences College of Pharmacy. The Germantown, Tenn., native earned her bachelor's degree in pharmacy, master's in pharmaceutical sciences and doctorate in pharmacy administration from UM. In 2007, she completed the Academic Leadership Fellows Program with the American Association of Colleges of Pharmacy. Her research interests focus on community pharmacy practice and using health behavior theories to study the provision, use and evaluation of pharmaceuticals and pharmacy. West-Strum has published more than 40 articles and presented more than 50 presentations at national meetings. She is active in the American Pharmacists Association and the National Community Pharmacists Association. She was the faculty liaison for the NCPA chapter at UAMS and was named NCPA Chapter Adviser of the Year in 2004. She edits the NCPA Digest, a comprehensive financial guide to community pharmacy. Yi Yang, M.D., Ph.D. University of Mississippi School of Pharmacy Assistant Professor University, MS Dr. Yi Yang is an Assistant Professor of Pharmacy Administration at the University of Mississippi. Yang received her Ph.D from both the University of Tennessee and Peking Union Medical College. She received her M.D. from China Medical University, China.